Below are current clinical trials.7 studies in Pancreas Transplant Program
(open studies only).
Filter this list of studies by location, status and more.
The purpose of this study is to confirm the effectiveness and safety of intravenous terlipressin in the treatment of adult patients who have hepatorenal syndrome (HRS) type 1.
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz.
The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antigen (HLA)-matched, living donor kidney transplants.
The aim of this study is to assess the quality of life among a sample of obese liver transplant recipients and compare it between those who underwent sleeve gastrectomy and those who did not.
Jacksonville, Fla., Rochester, Minn.
This study is being done to collect and store samples of blood from patients with liver disease for a research study to be able to find a new and better way to detect liver cancer.
Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz.
The purpose of this study is to connect the findings of TruGraf (a peripheral blood RNA signature that has been shown to correlate with rejection in kidney transplants) with rejection episodes in kidney transplant patients that are managed using standard of care clinical protocols at the three Mayo transplant sites.
The purpose of this study is to form a database collection of pancreas transplant recipients, of a large enough size that further studies can be carried out. The data collected will be shared and received by all institutions.
The purpose of this study is to collect and share detailed clinical data from all kidney transplant recipients from 7 kidney transplant centers (Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AZ; Mayo Clinic, Jacksonville, FL; Cornell University, New York, NY; University of Michigan, Ann Arbor, MI; Henry Ford, Detroit, MI; University of Pittsburgh Medical Center, Pittsburg, PA) to retrospectively and prospectively study kidney transplant recipients.
Jan. 17, 2018
- Barbara Woodward Lips Patient Education Center. Pancreas transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- U.S. News & World Report. U.S. News Best Hospitals 2015-16. http://health.usnews.com/best-hospitals/rankings. Accessed Feb. 22, 2016.
- Robertson RP. Pancreas and islet cell transplantation in diabetes mellitus. http://www.uptodate.com/home. Accessed April 7, 2016.
- Klein C, et al. Benefits and complications associated with kidney-pancreas transplantation in diabetes mellitus. http://www.uptodate.com/home. Accessed April 7, 2016.
- Barbara Woodward Lips Patient Education Center. Planning for your transplant: A financial guide. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
- Riggin ER. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 6, 2016.
- Eggebraaten KR (expert opinion). Mayo Clinic, Rochester, Minn. April 18, 2016.
- Heilman RL, et al. Immunosuppression in simultaneous pancreas-kidney transplantation. Drugs. 2010;70:793.
- Lu B, et al. Beta-cell targeted gene delivery for enhanced beta-cell proliferation. Human Gene Therapy. 2015;26:A63.
- Stulak JM, et al. Combined heart and abdominal organ transplantation: Excellent outcomes gained from a unique experience. Journal of Heart and Lung Transplantation. 2014;33(suppl):S278.
- Kudva YC (expert opinion). Mayo Clinic, Rochester, Minn. March 14, 2016.
- Pancreas Transplant. National Kidney Foundation. https://www.kidney.org/atoz/content/pancreastx. Accessed April 12, 2016.
Pancreas Transplant Program